Idiopathic steroid-sensitive nephrotic syndrome

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

3 events
Oct 2025A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis

Bio-Thera Solutions — PHASE2, PHASE3

TrialRECRUITING
May 2024Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD

Air Force Military Medical University, China — PHASE3

TrialNOT YET RECRUITING
Apr 2018The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Prof. Dr. Paul Brinkkoetter

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Idiopathic steroid-sensitive nephrotic syndrome.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials
1Unknown
1PHASE2, PHASE3
2Total recruiting
Search clinical trials for Idiopathic steroid-sensitive nephrotic syndrome

Recent News & Research

No recent news articles indexed yet for Idiopathic steroid-sensitive nephrotic syndrome.
Search PubMed for Idiopathic steroid-sensitive nephrotic syndrome

Browse all Idiopathic steroid-sensitive nephrotic syndrome news →

Specialist Network

Top 6 by expertise

View all Idiopathic steroid-sensitive nephrotic syndrome specialists →

Quick Actions